Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review) (2010)
- Authors:
- Autor USP: HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.3892/or_00001001
- Subjects: BIOLOGIA MOLECULAR; FENÓTIPOS; ADENOCARCINOMA; HPV (EPIDEMIOLOGIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: Oncology reports
- ISSN: 1021-335X
- Volume/Número/Paginação/Ano: v. 24, n. 6, p. 1419-1426, 2012
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
RAMALHO, Alan Saito et al. Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review). Oncology reports, v. 24, n. 6, p. 1419-1426, 2010Tradução . . Disponível em: https://doi.org/10.3892/or_00001001. Acesso em: 17 fev. 2026. -
APA
Ramalho, A. S., Lopes, A. D., Talans, A., Sakiyama, B. Y. P., Pereira, G. L. S., Hoff, P. M., & De Castro Jr., G. (2010). Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review). Oncology reports, 24( 6), 1419-1426. doi:10.3892/or_00001001 -
NLM
Ramalho AS, Lopes AD, Talans A, Sakiyama BYP, Pereira GLS, Hoff PM, De Castro Jr. G. Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review) [Internet]. Oncology reports. 2010 ; 24( 6): 1419-1426.[citado 2026 fev. 17 ] Available from: https://doi.org/10.3892/or_00001001 -
Vancouver
Ramalho AS, Lopes AD, Talans A, Sakiyama BYP, Pereira GLS, Hoff PM, De Castro Jr. G. Molecular targets for therapeutic interventions in human papillomavirus-related cancers (Review) [Internet]. Oncology reports. 2010 ; 24( 6): 1419-1426.[citado 2026 fev. 17 ] Available from: https://doi.org/10.3892/or_00001001 - Should patients with advanced colorectal cancer and ECOG 3/4 be treated with chemotherapy?
- Primary prevention of colorectal cancer: Myth or reality?
- Drogas moleculares
- Perspectivas no cuidado dos tumores gastrointestinais
- Obesidade e câncer
- Combination of capecitabine and oxaliplatin is an effective treatment option for advanced neuroendocrine tumors
- Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer
- Evidence-based recommendations for gastrointestinal cancers during the COVID-19 pandemic by the Brazilian Gastrointestinal Tumours Group
- Lack of association between ERCC1 expression in biliary tract malignancy and response to chemotherapy
- Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas
Informações sobre o DOI: 10.3892/or_00001001 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
